Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network In this randomized, open-label, multicenter ...
Efficacy of regorafenib (REG) in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial according to alpha-fetoprotein (AFP) and c-Met levels as predictors of poor prognosis. This ...
Compared with transarterial chemoembolization (TACE) alone, the combination of sorafenib and TACE may improve overall and progression-free survival in patients with recurrent intermediate-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback